Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Consumer health has seen demand dampened by consumers being confronted with very high inflation. The rate of 9.2% in 2022 was the highest experienced in decades. As a result, more consumers have been forced to prioritise household spending on…
Consumer health in Honduras experienced a year of growth in value terms in 2023 that was in line with the country's inflation. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, dermatologicals, and sports nutrition…
In general, consumer health in Kazakhstan is performing well towards the end of the review period. However, high inflation, increases in the costs of raw materials for the production of medicines and changed or disrupted logistics/supply routes have…
The harsh climatic conditions in Kuwait with extreme heat, rising pollution and large amounts of dust continue to play a key role in driving demand across key OTC categories, in particular analgesics and cough, cold and allergy (hay fever) remedies.…
Analgesics is expected to register moderate constant value growth in 2023. Though there was widespread severe flu in early 2023, cough and cold remedies are not expected to benefit to a huge degree, as most of these patients were hospitalised or put…
Cough, cold and allergy (hay fever) remedies are widely consumed consumer health items in the Guatemalan market. These products have established broad distribution throughout the country, with products available throughout the modern and traditional…
Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…
Dermatologicals is expected to register moderate constant value growth in 2023. Geopolitical tensions in the region have led to a significant increase in the number of immigrants from Ukraine, Russia and Belarus, and this is expected to contribute to…
Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…
Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…